A new vaccine for Ebola showed high efficacy in preventing the development of Ebola in clusters of people exposed to the virus, and protection was also conferred to those who were not vaccinated.
A small percentage of Ebola virus survivors have a novel retinal lesion as a result of the disease.
The number of suspected Ebola cases in the Democratic Republic of Congo has risen to 37.
A strategy of preemptive use of an AD26.ZEBOV followed by MVA-BN-Filo immunization schedule in at-risk populations may offer advantages over reactive use of single-dose vaccine regimens.
Changes in messenger RNA abundance proved to be a reliable means of predicting patient's chances of surviving Ebola virus disease.
Liberia's Men's Health Screening Program for Ebola survivors successful in spite of complex challenges.
Virus is more likely to be found in male survivors older than 40, researchers report.
The FDA's Breakthrough Therapy Designation is intended to expedite the development and review of a candidate vaccine that is planned for use, alone or in combination, to treat a serious or life-threatening disease or condition.
The CDC releases infection control measures implemented at a Texas hospital.
Approximately one-fifth developed severe or total vision loss within weeks of recovery.
Antibody is cost-effective, reducing economic burden that may result from this dangerous virus.
Sign Up for Free e-newsletters
Infectious Disease Advisor Articles
- Antibiotic-Resistant Bacteria Have Long Resided on Ready-to-Eat Foods
- Infections Complicate Biologic Use in Autoimmune Inflammatory Disorders
- Tuberculosis Vaccine May Reverse Type 1 Diabetes
- No Benefits Seen for Adjunctive Clindamycin in Cellulitis
- Telbivudine During Early Pregnancy Prevents HBV Transmission
- Maternal Antibodies Hinder Antigenic Responses to Vaccines in Infants
- Sepsis-Related Mortality Decreased With Rapid Implementation of Protocol
- New Assay Targets Susceptibility to Ciprofloxacin in Gonorrhea
- Gut Microbiota Associated With Parkinson's Disease Progression
- Decrease Rate of S aureus Resistance Seen With Certain Antibiotics